Skip to content

SANA SANA BIOTECHNOLOGY INC

Follow

COM (common), issuer CIK 1770121

204 managers (212 13F filers) reported a position in SANA shares at 2026-06-30, 184,772,582 shares in all. 30 filers opened a position and 21 filers sold out during the quarter.

Managers
204
13F filers
212
New
30
Added
67
Reduced
66
Sold out
21
Shares held by filers
184,772,582

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

The latest Form 4 transactions, non-derivative.
OwnerDateSharesPriceFiling
Bishop Hans Edgardirector2026-10-05+8,680 A$0Form 4

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
Axiom Investment Management LLC20$70<0.01%new13F-HRTimeline
Keating Financial Advisory Services, In…1$3<0.01%new13F-HRTimeline
Covestor Ltd87$00%+6113F-HRTimelineValue filed as zero, left out of ratios.
Activest Wealth Management0$00%-16,30013F-HRTimelineValue filed as zero, left out of ratios. Amount filed as zero, left out of ratios.

Events

  • Bishop Hans Edgar acquired 8,680 SANA shares on 2026-10-05, Form 4 filed 2026-10-06. 0001480212-26-000010

    Accepted , ingested